header
Image from OpenLibrary

Association between single nucleotide polymorphism of the inflammatory cytokine genes : Tumor necrosis factor-Ü and tumor necrosis factor-Ý and chronicity in Egyptian pediatric patients with immune thrombocytopenia / Alaa Eid Hussein ; Supervised Nesrine Elgharbawi , Mona Elghamrawy , Gehan Hamed Shahin

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Alaa Eid Hussein , 2016Description: 145 P. : charts , facsimiles ; 25cmOther title:
  • العلاقة بين تعدد الأشكال النووية المنفردة فى جينات السيتوكينات : عامل نخر الورم{u٢٠١٣}أ و عامل نخر الورم{u٢٠١٣}ب و الإزمان فى الأطفال المصريين المرضى بنقص الصفائح الدموية المناعى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder caused by the production of anti-platelet antibodies. These autoantibodies opsonize platelets for splenic clearance, resulting in low levels of circulating platelets. The current case-control study aimed at detecting TNF-Ü (-308 G/A) and TNF-Ý (+252 A/G) genes polymorphism in Egyptian children with chronic ITP to clarify their possible association with chronic evolution of the disease. The current study included 80 chronic ITP patients and 100 matched unrelated healthy controls. Genotyping was performed by using polymerase chain reaction restriction fragment length polymorphism technique (PCR-RFLP). TNF-Ü genotyping revealed that wild G/G, heterozygous G/A and homozygous A/A genotypes among cITP patients were 81.2%, 15% and 3.8% respectively versus 79%, 20% and 1% in the control group, while TNF-Ý genotyping revealed that wild A/A, heterozygous A/G and homozygous G/G genotypes among cITP patients were 55%, 40% and 5% respectively versus 60%, 28% and 12% in the control group, with no statistically significant difference between the two groups. Patients having homozygous genotype of TNF-Ü or TNF-Ý showed higher mean age, longer disease duration & had lower mean platelet count with statistically significant difference from the other genotypes. TNF-Ü polymorphism was more frequent among unresponsive patients compared to responsive patients with statistically significant difference. It was found that patients with combined genes polymorphism had three fold increased risk of development of chronic ITP compared to control group
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2016.Al.A (Browse shelf(Opens below)) Not for loan 01010110071533000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2016.Al.A (Browse shelf(Opens below)) 71533.CD Not for loan 01020110071533000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder caused by the production of anti-platelet antibodies. These autoantibodies opsonize platelets for splenic clearance, resulting in low levels of circulating platelets. The current case-control study aimed at detecting TNF-Ü (-308 G/A) and TNF-Ý (+252 A/G) genes polymorphism in Egyptian children with chronic ITP to clarify their possible association with chronic evolution of the disease. The current study included 80 chronic ITP patients and 100 matched unrelated healthy controls. Genotyping was performed by using polymerase chain reaction restriction fragment length polymorphism technique (PCR-RFLP). TNF-Ü genotyping revealed that wild G/G, heterozygous G/A and homozygous A/A genotypes among cITP patients were 81.2%, 15% and 3.8% respectively versus 79%, 20% and 1% in the control group, while TNF-Ý genotyping revealed that wild A/A, heterozygous A/G and homozygous G/G genotypes among cITP patients were 55%, 40% and 5% respectively versus 60%, 28% and 12% in the control group, with no statistically significant difference between the two groups. Patients having homozygous genotype of TNF-Ü or TNF-Ý showed higher mean age, longer disease duration & had lower mean platelet count with statistically significant difference from the other genotypes. TNF-Ü polymorphism was more frequent among unresponsive patients compared to responsive patients with statistically significant difference. It was found that patients with combined genes polymorphism had three fold increased risk of development of chronic ITP compared to control group

Issued also as CD

There are no comments on this title.

to post a comment.